Skip to main content

Table 1 Serum tumor markers and clinicopathologic factors of the patients

From: Prognostic significance of tumor markers in T4a gastric cancer

Factors (n) AFP(+)
n (%)
P CEA(+)
n (%)
P CA19-9(+)
n (%)
P CA50(+)
n (%)
P
Sex   0.408   0.029   0.213   0.242
  Male (192) 13 (6.8)   37 (19.3)   67 (34.9)   61 (31.8)  
  Female (81) 3 (3.7)   7 (8.6)   22 (27.2)   20 (24.7)  
Age (years)   0.053   0.779   0.047   0.017
  ≤40 (26) 4 (15.4)   3 (11.5)   13 (50.0)   13 (50.0)  
  >40 (247) 12 (4.9)   41 (16.6)   76 (30.8)   68 (27.5)  
Tumor site   0.153   0.014   0.011   0.004
  Upper (90) 5 (5.6)   16 (17.8)   31 (34.4)   31 (34.4)  
  Middle (52) 3 (5.8)   5 (9.6)   19 (36.5)   15 (28.9)  
  Lower (124) 6 (4.8)   19 (15.3)   33 (26.6)   29 (23.4)  
  ≥Two-third (7) 2 (28.6)   4 (57.1)   6 (85.7)   6 (85.7)  
Tumor size   0.063   0.812   0.102   0.014
  ≤6 (178) 7 (3.9)   28 (15.7)   52 (29.2)   44 (24.7)  
  >6 (95) 9 (9.5)   16 (16.8)   37 (38.9)   37 (38.9)  
Borrmann type   0.010   0.365   0.086   0.066
  I (15) 0 (0.0)   2 (13.3)   4 (26.7)   3 (20.0)  
  II (8) 1 (12.5)   0 (0.0)   4 (50.0)   2 (25.0)  
  III (228) 10 (4.4)   36 (15.8)   69 (30.3)   64 (28.1)  
  IV (22) 5 (22.7)   6 (27.3)   12 (54.6)   12 (54.6)  
N stage   0.065   0.001   0.000   0.000
  N0 (49) 0 (0.0)   3 (6.1)   7 (14.3)   6 (12.2)  
  N1 (49) 1 (2.0)   6 (12.2)   14 (28.6)   14 (28.6)  
  N2 (52) 4 (7.7)   3 (5.8)   10 (19.2)   9 (17.3)  
  N3 (123) 11 (8.9)   32 (26.0)   58 (47.2)   52 (42.3)  
Nervous invasion   0.156   0.520   0.051   0.294
  + (197) 9 (4.6)   30 (15.2)   71 (36.0)   62(31.5)  
  - (76) 7 (9.2)   14 (18.4)   18 (23.7)   19 (25.0)  
Lymphovascular invasion   0.399   0.212   0.004   0.085
  + (196) 10 (5.1)   35 (17.9)   74 (37.8)   63(32.7)  
  - (77) 6 (7.8)   9 (11.7)   15 (19.5)   17 (22.1)  
  1. Figures shown in parentheses are percentages.